The Jury Is Still Out on the Benefits and Harms of Methylphenidate for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Ole Jakob Storebø, Erlend Faltinsen, Morris Zwi, Erik Simonsen, Christian Gluud

13 Citations (Scopus)

Abstract

Much remains unclear about the benefits and harms of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Between 2012 and 2018, we conducted two Cochrane systematic reviews on methylphenidate for ADHD. This article explores the main findings in relation to evidence-based practice and our current understanding of ADHD.

Translated title of the contribution基于发病机制治疗遗传性神经发育障碍的未来之路
Original languageEnglish
JournalClinical Pharmacology and Therapeutics
Volume104
Issue number4
Pages (from-to)606-609
ISSN0009-9236
DOIs
Publication statusPublished - 13 Jul 2018

Fingerprint

Dive into the research topics of 'The Jury Is Still Out on the Benefits and Harms of Methylphenidate for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder'. Together they form a unique fingerprint.

Cite this